Home | About CytoJournalEditorial Board | Archived articles | Search CytoJ Articles | Subscribe | Peer review policies | CytoJournal Quiz Cases
  Reviewer corner | Author corner | OA Steward’s corner | CF member’s corner | Join as CF member | Manuscript submission | Open Access (OA) Advocacy
Home
CytoJournal All 'FULL TEXT' in HTML are FREE under "open access" charter of CytoJournal.
To login for downloading any PDF OR to request TOC (Table of Content) by e-mail, please click here
Home Email this page Print this page Small font size Default font size Increase font size Cytopathology Foundation
Navigate here
  Search
 
  
Resource links
 »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »  Article in PDF (778 KB)
 »  Citation Manager
 »  Access Statistics
 »  Reader Comments
 »  Email Alert *
 »  Add to My List *
* Registration required (free)  

 
  In this article
 » Acknowledgments
 »  Competing intere...
 »  Authorship state...
 »  Ethics statement...
 »  List of abbrevia...
 »  References
 »  Article Figures

 Article Access Statistics
    Viewed3076    
    Printed5    
    Emailed0    
    PDF Downloaded8    
    Comments [Add]    

Recommend this journal

 


 
Browse articles
LETTER TO EDITOR
CytoJournal 2015,  12:24

The route of science: Labyrinths and algorithms - Inspirations by human papillomavirus testing and cervical cancer


1 Department of Pathology, Istanbul K.S.S Training Hospital, Istanbul, Turkey
2 Department of Pathology and Cytology, Ankara Diskapi Teaching and Research Hospital, Ankara, Turkey

Date of Submission13-Apr-2015
Date of Acceptance28-Jul-2015
Date of Web Publication23-Oct-2015

Correspondence Address:
Binnur Onal
Department of Pathology and Cytology, Ankara Diskapi Teaching and Research Hospital, Ankara
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1742-6413.168061

Rights and Permissions



How to cite this article:
Uhri M, Onal B. The route of science: Labyrinths and algorithms - Inspirations by human papillomavirus testing and cervical cancer. CytoJournal 2015;12:24

How to cite this URL:
Uhri M, Onal B. The route of science: Labyrinths and algorithms - Inspirations by human papillomavirus testing and cervical cancer. CytoJournal [serial online] 2015 [cited 2017 Oct 18];12:24. Available from: http://www.cytojournal.com/text.asp?2015/12/1/24/168061

Editorial/Peer Review Statement
To ensure the integrity and the highest quality of CytoJournal publications, the review process of this manuscript was conducted under a double blind model (authors are blinded for reviewers and vice versa) through automatic online system.


Popper's landmark work, Logik der Forschung (The Logic of Scientific Discovery) (1959), starts with the lines: "Without a doubt, the collective scientific knowledge of mankind is the greatest miracle of the world." [1] According to Popper, a theory should not only be "verified" but should also be "tested" and even "objectified" for it to be considered as scientific. He argues that pursuit of knowledge is only possible because of the objections to and versatility of said knowledge. Popper remarks that "when referring to human knowledge, he will usually have this objective sense of the word 'knowledge' in mind." [2] These concepts are clarified in the following lines:

The falsification of the prediction shows the explanation is false, yet the reverse of this does not hold. It is incorrect and grossly misleading to think that we can interpret the "verification" of the prediction as "verifying" the explanation or even a part of it, for a true prediction may easily have been validly deduced from an explanation that is false. It is even quite misleading to regard every "verification" of a prediction as something like a practical corroboration of the explanation. It would be more correct to say that only such "verifications" of predictions which are "unexpected" (without the theory under examination) may be regarded as corroborations of the explanation, and so of the theory… [2]

Popper states that researchers are often too blinded by facts to deliberate on the meaning of these facts. He contends that seemingly useless bits of uncovered information can, in the long-term, with the help of additional innovative information, help in solving puzzles or creating mosaics to discover the complete meaning. Popper's view was further developed by Kuhn, Feyerabend, and Lakatos. On the other hand, according to Maxwell, [3] who opposed this view, "…Science dissociated from the pursuit of wisdom, (is) the result of our failure to put right the structural defects in academic inquiry, inherited from the blunders of the enlightenment."

Humanity's advancement in the field of science throughout the course of history can be likened to infant taking steps in a huge Labyrinth [Figure 1]. Getting closer to one's destination in a Labyrinth does not necessarily mean that the correct path is being followed. The progress of human knowledge is a result of the tireless wanderings of scientists through the Labyrinths of truth. For thousands of years, humanity has been mapping new frontiers, discovering new Labyrinths, and finding new avenues of the doubt. Thanks to this unending march, we are able to devise new explanations and algorithms to guide our way.

The concept of the Labyrinth is deeply etched in mythology reflecting humanity's shared consciousness in seeking to find ways out of seemingly impossible situations and to reach a goal or truth through the innovation and perseverance. The Minoan culture of Crete was associated wıth the double-headed axe or Labrys and of course it was there that the classical Labyrinth was built for King Minos at Knossos to house the fearful beast called the Minotaur. The Athenian hero Theseus was able to find his way to the center, slay the monster, and find his way out again by retracing his steps with the help of a ball of string. In Greek mythology; the double-headed axe, Labrys was wielded by Zeus. One side pierced through the darkness while the other side was used to split the head of the creator god Zeus himself, scattering the light trapped inside him, and giving birth to Athena, the goddess of wisdom. In modern usage, a Labyrinth is an intricate combination of paths or passages in which it is difficult to find one's way or to reach the exit.
Figure 1: The Labyrinth

Click here to view


Scientists were the first to discover the Labyrinths that we call paradigms and introduce them to the light of day. Pioneers take the most difficult paths in the darkness of uncharted territory before others have the courage to do so. Those following in their wake can thus find the way and draw up the maps. Once the enlightenment at the end of the Labyrinth has been reached; graphs, flowcharts, and algorithms must be created in order to enable others to use this knowledge without losing their way.

Therefore, a scientist focuses on where a particular piece of knowledge fits into the grand puzzle, but he must not be in a rush to view the grand picture. On the other hand, as science is inevitably involved with industrial and commercial interactions; skepticism may be seen as a waste of time by those who are pressing for urgent application of this knowledge. The path leading to the greater good may be seen as a diversion by those with the profit idea in mind. For them, turning knowledge into a product without delay may be perceived as the priority. An example of the latter can be seen in the case of new drugs that hit the market with much ado, but are later forcibly recalled after the revelation that they had not been properly tested. [4],[5] These labyrinthine roads which lead to blind alleys are being increasingly publicized. This situation can result in public disappointment and, unfortunately, in a distrust of science and scientists.

In recent years, medical science has witnessed an explosive growth in the recognition and understanding of the molecular genetic abnormalities that drive the development and progression of various cancers. Furthermore, the therapeutic relevance of these abnormalities mandates that molecular testing be performed in order to facilitate management decisions. Therefore, to ensure timely and appropriate patient management, the judicious and effective integration of molecular ancillary testing with cytopathology specimens is called for Human papillomavirus (HPV) testing on cervical cytology specimens is one of the salient examples illustrating the intimate interface between cytopathology and molecular diagnostics. [6]

The molecular biology of the papilloma virus family is a rapidly developing field. Since the 1970s, special attention has been given to their interactions, which lead to benign or malignant proliferations, with emphasis on human cancer. [7] The HPV relationship with cervical cancer has provided significant hope for a breakthrough in the struggle against cancer in the last decade. [8] Moreover, with the expectation of preventing cervical cancer, the proliferation of HPV tests and vaccines on the market has accelerated, despite the fact that it is too early to evaluate the outcome in terms of cervical cancer incidence and mortality rates. As a "reflex test" in the triage of low-grade epithelial abnormalities, high-risk HPV (hrHPV) testing has improved the patient pathway by reducing unnecessary referrals and returning women to normal recall much earlier. Similarly, as the "test of cure" in high-grade cervical intraepithelial neoplasia, hrHPV testing has greatly improved patient management and has been highly cost efficient. [9] However, in spite of a considerable amount of hope and anticipation, the results of the first trials have not been quite what was expected in terms of the acceptable specificity of hrHPV testing for intraepithelial lesions [10],[11] or even for invasive cancers. [12],[13] This may possibly be due to several parameters such as the episodic nature of HPV infections, L1 deletions, molecular biology of early invasive lesions, or the variety of sampling methods.

In addition, unnecessary surgical interventions may have increased because scientists have been trying to make advanced analyses to determine the viral agent, which is highly capable of presenting temporary and mostly reversible appearances. With time, concentrating on hrHPV testing as co-testing or HPV-only primary screening modality; instead of the time-honored algorithms based on Papanicolaoutest may demonstrate an effect on the treatment of cervical cancer. For the time being; the best hrHPV test, the most appropriate cut-off value, testing algorithms and the right collection media needs to be determined through scientific falsifiability and its requirements of being tested, verified, and objectified.

In the context of the "architecture of knowledge" objectified knowledge is explicit, codifiable, transmittable without bias, through the language, and generic. It refers to knowledge that serves as a platform to investigate new empirical phenomena. Blackler refers to this category of knowledge as "encoded" knowledge. As it is indicated by Amin, objectified knowledge corresponds essentially to the "know-why" in Lundvall and Johnson's typology (referring to the scientific knowledge of principles in the human mind and in society). [14] As Popper pointed out, in order to remain within the bounds of scientific and critical thinking required by falsifiability; the criteria of testability, verifiability, and objective evaluation must be met. The most striking example of the application of these criteria in the last century can be seen in the discovery of the Higgs field and Higgs boson. Peter Higgs put forward the beginnings of a scientific theory in 1960s in which he proposed energy conversion material particles. The particle theory of transformation which allows for the energy of the material particles to be produced independently from one another was investigated by repeated experiments with two different teams. These experiments (ATLAS - A Toroidal, LHC Apparatus, and CMS experiments) along with the theory exhibited the capability of being tested were open to transparent evaluation of the data obtained and were bound by objective evaluation criteria. Furthermore, attempts were made at falsification. However, ultimately, the key agent particle in energy conversion (the God particle) was discovered. [15],[16] The existence of the Higgs boson has been nearly universally acknowledged and as a mere observer of the process, Peter Higgs received the 2013 Nobel Prize in Physics for his theory. [17]

The current era of personalized "precision medicine" continues to evolve at an accelerated pace. Thus, effective multidisciplinary collaboration and coordination amongst cytopathologists, surgical pathologists, molecular pathologists, and clinicians becomes even more essential. The ultimate goal of these multidisciplinary efforts is to devise "best practice" approaches, with the selection of appropriate molecular tests while avoiding inappropriate and unnecessary testing. Within the setting of escalating health care costs associated with laboratory testing as well as with targeted therapy, the judicious and effective use of molecular tests is paramount. [6]

Scientists must continue their unrestricted and also skeptical research to find the truthfulness of the new route in the "Labyrinth." Some may see this scientific skepticism concerning research as an unnecessary indulgence. However, "skepticism" has been the traditional way in which humanity has developed scientific knowledge throughout the centuries.

Skepticism is not a position, but the process of applying reason and critical thinking to determine validity. The scientific method requires evidence, preferably based upon validated testing. In the case of "HPV and cervical cancer," skepticism is a meaningful component also in clarification of the "correlation proving causation," [18] since the testing of which is not yet accepted as being "state-of-the-art" or the "best practice," as a primary screening model.

The desire of a scientist is to continue uncovering Labyrinths, to find the correct routes using algorithms and to continue living by the principles of scientific thinking, with the goal to serve mankind in the light of wisdom, hopefully without time constraints or industrial pressures.


 » Acknowledgments Top


The authors would like to thank Dr. Taner Φzek, MD, a master of caricature, for his original artwork in [Figure 1] (Page 2) and Prof. Dr. Muzaffer Metinta°, MD for his critical reading.


 » Competing interests statement by all authors Top


Both authors declare no competing interests.


 » Authorship statement by all authors Top


Both authors of this article declare that they qualify for authorship as defined by the ICMJE. Both authors are responsible for the conception of this study, have participated in its design and coordination, and helped to draft the manuscript. Both authors have read and approved the final manuscript.


 » Ethics statement by all authors Top


This manuscript is in form of a letter. Therefore, institutional ethical approval is not mandatory. The caricature is original, prepared for this manuscript.


 » List of abbreviations Top


0(In alphabetic order)[TAG:2][/TAG:2]

HPV - Human papillomavirus

hrHPV - high-risk Human papillomavirus

 
 » References Top

1.
Popper K. The Logic of Scientific Discovery. Vienna, Austria: Logik der Forschung, First Published in 1935 by Verlag von Julius Springer, First English Edition Published in 1959 by Hutchinson and Co.; First published in 1992 by Routledge p. xxvi.  Back to cited text no. 1
    
2.
Popper KR. Objective Knowledge: An Evolutionary Approach. Revised Edition. Oxford: Clarendon Press; 1979. p. 286, 353-4.  Back to cited text no. 2
    
3.
Maxwell N. Basic Argument for the Need for an Intellectual Revolution. Available from: http://www.knowledgetowisdom.org. [Last accessed on 2007 Nov 30.  Back to cited text no. 3
    
4.
Kim PS, Reicin AS. Rofecoxib, Merck, and the FDA. N Engl J Med 2004;351:2875-8.  Back to cited text no. 4
    
5.
Sawada T, Yamada H, Dahlöf B, Matsubara H, for the KYOTO HEART Study Group. Retraction of: Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study. Eur Heart J 2009;30:2461-9.  Back to cited text no. 5
    
6.
American Society of Cytopathology (ASC) and Papanicolaou Society of Cytopathology (PSC). Joint Position Statement on The Use of Molecular Testing on Cytologic Specimens; Nov 25 2014. Available from: . [Last accessed on 2013 May 12].  Back to cited text no. 6
    
7.
Syrjanen K. Papilloma virüs infections and cancer. In: Syrjanen K, Gissmann L, Koss LG, editors. Papilloma Viruses and Human Disease. New York: Springer-Verlag; 1987. p. 467.  Back to cited text no. 7
    
8.
The Nobel Prize in Physiology or Medicine 2008. Nobelprize.org. Nobel Media AB 2014. Web. 22 Aug 2015.  Back to cited text no. 8
    
9.
Dudding N, Smith P (course tutors). Courses for Medical Staff. Borderline High Grade Lesions and the Use of HPV Triage and Test of Cure. Available from: http://www.cytologytraining.co.uk/. [Last accessed on 2013 May 12].  Back to cited text no. 9
    
10.
Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER Cancer Statistics Review, 1975-2011. SEER Data Submission, Posted to the SEER. Bethesda, MD: National Cancer Institute; 2013. Available from: http://www.seer.cancer.gov/csr/1975_2011. [Last accessed on 2014 Dec 17].  Back to cited text no. 10
    
11.
Kitchener HC, Almonte M, Thomson C, Wheeler P, Sargent A, Stoykova B, et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): A randomised controlled trial. Lancet Oncol 2009;10:672-82.  Back to cited text no. 11
    
12.
Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: A population-based study in routine clinical practice. Lancet Oncol 2011;12:663-72.  Back to cited text no. 12
    
13.
Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJ, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: Follow-up of four European randomised controlled trials. Lancet 2014;383:524-32.  Back to cited text no. 13
    
14.
Amin A, Cohendet P. Architectures of Knowledge: Firms, Capabilities, and Communities. Oxford, Oxford University Press; 2004. p. 34.  Back to cited text no. 14
    
15.
Ellis J. Before, behind and beyond the discovery of the Higgs boson. Philos Trans A Math Phys Eng Sci 2015 Jan 13;373:(2032):20140049.  Back to cited text no. 15
    
16.
Ball A. Technical challenges of the Large Hadron Collider experiments (ATLAS and CMS). Available from: http://www.rsta.royalsocietypublishing.org/content 2014  Nov 24/373/2032/20140045. [Last accessed on 2013 May 12].  Back to cited text no. 16
    
17.
The Nobel Prize in Physics 2013 Available from: http://www.nobelprize.org/nobel_prizes/physics/laureates/2015.08.22. [Last accessed on 2013 May 12].  Back to cited text no. 17
    
18.
Bauer H. Available from: http://www.scimedskeptic.wordpress.com/tag/hpv-andca. [Last accessed on 2013 May 12].  Back to cited text no. 18
    


    Figures

  [Figure 1]



 

Top
Previous article Next article

    

  Site Map | Copyright and Disclaimer
© 2007 - CytoJournal | A journal by Cytopathology Foundation Inc with Wolters Kluwer - Medknow
New version online since 1st July '08
Open Access